| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Human Resources Officer
1 company
Nicola Deidre Petal Greenway is Chief Human Resources Officer at TKPHF. Nicola Deidre Petal Greenway's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $1.7M at current prices.
The TKPHF filings lean toward selling, a net 54,357 shares.
Nicola Deidre Petal Greenway has 4 Form 4 filings on record from July 2026 to August 2026, all as Chief Human Resources Officer at Takeda Pharmaceutical (TKPHF), 2026.
The 5 reported transactions were 4 open-market sales and 1 stock award.
Counted by filing, the open-market trades come to no purchases and 3 sales worth about $957K.
The largest open-market sale was 34,603 shares of TKPHF at an average $17.51 on August 10, 2026, about $606K.
None of the 3 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 18, 2026 | TKPHF Takeda Pharmaceutical Company Limited | Chief Human Resources Officer | Sell | 12,980 | $18.11 | $235,118.42 | -24.5% | |
| Aug 10, 2026 | TKPHF Takeda Pharmaceutical Company Limited | Chief Human Resources Officer | Sell | 34,603 | $17.51 | $605,777.81 | -36.7% | |
| Aug 10, 2026 | TKPHF Takeda Pharmaceutical Company Limited | Chief Human Resources Officer | Sell | 6,774 | $17.10 | $115,835.40 | -11.3% |